Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020)
Harmony Biosciences Holdings recorded quarterly Preferred Dividend Payments of $6.0 million in Q3 2020, down 42.44% quarter-over-quarter from $10.4 million in Q2 2020, and down 33.39% year-over-year from $9.0 million in Q4 2019.
Harmony Biosciences Holdings' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $6.0 million for Q3 2020.
- In Q3 2020, Preferred Dividend Payments fell 33.39% year-over-year to $6.0 million; the TTM figure through Dec 2020 stood at $26.9 million (changed N/A YoY), while the FY2020 annual figure was $26.9 million, down 23.64% from the prior year.
- Preferred Dividend Payments came in at $6.0 million for Q3 2020 at Harmony Biosciences Holdings, down from $10.4 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $10.4 million in Q2 2020 to a low of $6.0 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 6.01 Mn |
| Jun 30, 2020 | 10.45 Mn |
| Mar 31, 2020 | 10.45 Mn |
| Dec 31, 2019 | 9.58 Mn |
| Sep 30, 2019 | 9.03 Mn |